THE MINIMED™ 670G HYBRID AUTOMATED INSULIN DELIVERY SYSTEM: SETTING THE RIGHT EXPECTATIONS

被引：4
|
作者：
Leelarathna, Lalantha
Thabit, Hood
机构：
[1] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Diabet Ctr, Manchester, Lancs, England
[2] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Fac Biol Med & Hlth, Manchester, Lancs, England
来源：
ENDOCRINE PRACTICE | 2018年 / 24卷 / 07期
关键词：
EXPERIENCE; ADULTS;
D O I：
10.4158/EP-2018-0242
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：698 / 700
页数：3
相关论文
共 50 条
  • [41] An analysis of Medtronic MiniMed 670G insulin pump use in clinical practice and the impact on glycemic control, quality of life, and compliance
    Horowitz, Maxwell E.
    Kaye, William A.
    Pepper, Gary M.
    Reynolds, Kathryn E.
    Patel, Shital R.
    Knudson, Kort C.
    Kale, Geetanjali K.
    Gutierrez, Maria E.
    Cotto, Leslie A.
    Horowitz, Barry S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [42] Glycemic control outcomes of adults using the MiniMed™ 670G hybrid closed-loop (HCL) system: A single-center study
    Al Qifari, S. F.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 158
  • [43] Safety and Efficacy of Medtronic MiniMed 670G Hybrid Closed-Loop System in the Diabetes Camp Setting: Comparison of Auto Mode (AM) vs. Manual Mode (MM)
    Chan, Sophia H.
    Chang, Erica W.
    Tang, Jonathan K.
    Schmeltz, Lowell
    DIABETES, 2019, 68
  • [44] INTEGRATED INSULIN PUMP AND CONTINUOUS GLUCOSE MONITORING TECHNOLOGY IN DIABETES CARE TODAY: A PERSPECTIVE OF REAL-LIFE EXPERIENCE WITH THE MINIMED™ 670G HYBRID CLOSED-LOOP SYSTEM
    Aleppo, Grazia
    Webb, Kimberly M.
    ENDOCRINE PRACTICE, 2018, 24 (07) : 684 - 692
  • [45] In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes
    Wood, Michael A.
    Shulman, Dorothy I.
    Forlenza, Gregory P.
    Bode, Bruce W.
    Pinhas-Hamiel, Orit
    Buckingham, Bruce A.
    Kaiserman, Kevin B.
    Liljenquist, David R.
    Bailey, Timothy S.
    Shin, John
    Huang, Suiying
    Chen, Xiaoxiao
    Cordero, Toni L.
    Lee, Scott W.
    Kaufman, Francine R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (11) : 731 - 737
  • [46] Maintaining Glucose Control at One plus Year of MiniMed® 670G System Home Use: Single Center Experience
    Garg, Satish K.
    Slover, Robert
    Giordano, Dominique
    Forlenza, Gregory P.
    Lee, Scott
    Shin, John
    Kaufman, Francine
    DIABETES, 2017, 66 : LB33 - LB33
  • [47] FIASP INSULIN STABILITY IN THE EXTENDED WEAR INFUSION SET AND ON-MARKET INFUSION SETS: AN IN-VITRO SAMPLES COMPARISON WITH THE MINIMED™ 670G SYSTEM
    Fusselman, H.
    Chambers, C.
    Chattaraj, S.
    Geissinger, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A151 - A151
  • [48] A REAL-WORLD EVALUATION OF AUTOMATED INSULIN DOSING SYSTEMS DEMONSTRATES SUPERIOR EFFICACY AND COMPARABLE SAFETY WITH OPEN-SOURCE SYSTEMS AS COMPARED TO MINIMED 670G
    Jeyaventhan, R.
    Gallen, G.
    Choudhary, P.
    Hussain, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A95 - A95
  • [49] ULTRA RAPID LISPRO (URLI) DEMONSTRATES SIMILAR TIME IN TARGET RANGE TO LISPRO WITH THE MEDTRONIC MINIMED 670G HYBRID CLOSED-LOOP SYSTEM
    Carlson, A.
    Liu, R.
    Hardy, T.
    Boyd, J.
    Bergenstal, R.
    Morrett, S.
    Ignaut, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A85 - A86
  • [50] Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMed™ 670G hybrid closed-loop system in simulated trials compared to NovoLog®
    Grosman, Benyamin
    Wu, Di
    Parikh, Neha
    Roy, Anirban
    Voskanyan, Gayane
    Kurtz, Natalie
    Sturis, Jeppe
    Cohen, Ohad
    Ekelund, Magnus
    Vigersky, Robert
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2021, 205
12345